Clinical Trial Update: Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in women with diarrhea-predominant irritable bowel syndrome that failed conventional therapy has completed; sponsor is GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: GlaxoSmithKline | Conditions: Irritable Colon, Irritable Bowel Syndrome (IBS) | Phase 3 | Status: COMPLETED